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To maintain the female reproductive lifespan, the majority of ovarian primordial follicles are preserved in a
quiescent state in order to provide ova for later reproductive life. However, the molecular mechanism that
maintains the long quiescence of primordial follicles is poorly understood. Here we provide genetic evidence
to show that the tumor suppressor tuberous sclerosis complex 1 (Tsc1), which negatively regulates mamma-
lian target of rapamycin complex 1 (mTORC1), functions in oocytes to maintain the quiescence of primordial
follicles. In mutant mice lacking the Tsc1 gene in oocytes, the entire pool of primordial follicles is activated
prematurely due to elevated mTORC1 activity in the oocyte, ending up with follicular depletion in early adult-
hood and causing premature ovarian failure (POF). We further show that maintenance of the quiescence of
primordial follicles requires synergistic, collaborative functioning of both Tsc and PTEN (phosphatase and
tensin homolog deleted on chromosome 10) and that these two molecules suppress follicular activation
through distinct ways. Our results suggest that Tsc/mTORC1 signaling and PTEN/PI3K (phosphatidylinositol
3 kinase) signaling synergistically regulate the dormancy and activation of primordial follicles, and together
ensure the proper length of female reproductive life. Deregulation of these signaling pathways in oocytes
results in pathological conditions of the ovary, including POF and infertility.
INTRODUCTION
In the mammalian ovary, the pool of primordial follicles is
the source of ova for the entire reproductive life. To main-
tain the normal length of female reproductive life, the
majority of primordial follicles must be maintained in a
quiescent state for later use (1–3). In order to produce
mature ova, primordial follicles are recruited from the reser-
voir of dormant follicles into the growing follicular pool,
through a process termed follicular activation or initial
recruitment, and subsequently undergo a series of
follicular development (2). Menopause, or ovarian senes-
cence, occurs when the pool of primordial follicles has
become exhausted (4–6).
Investigation of the molecular mechanisms that sustain the
long dormancy of primordial follicles is still in its infancy
(7). Recently, our studies revealed that PTEN (phosphatase
and tensin homolog deleted on chromosome 10), a negative
regulator of PI3K (phosphatidylinositol 3 kinase), functions
in oocytes as a suppressor of follicular activation (8). We
also found that the PI3K–PDK1 (3-phosphoinositide-
dependent protein kinase-1)–Akt–S6K1 (p70 S6 kinase 1)–
rpS6 (ribosomal protein S6) cascade in primary oocytes
regulates ovarian aging by regulating the survival of primor-
dial follicles (9). These results indicate that PTEN/PI3K sig-
naling within the oocyte is of importance in determining the
developmental courses of the primordial follicles, including
their survival, their activation and their demise.
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oocytes, the activation of S6K1–rpS6 is largely dependent on
mammalian targetofrapamycincomplex1 (mTORC1)(8),indi-
cating that mTORsignaling may bea regulatorynetworkassoci-
ated with control of the development of primordial follicles.
mTORC1 is a serine/threonine kinase that regulates cell
growth and proliferation in response to growth factors and
nutrients. It functions by modulating processes such as
protein synthesis, ribosome biogenesis and autophagy (10–
12). In human cells, mTORC1 activity is negatively regulated
by a heterodimeric complex consisting of two protein mol-
ecules: tuberous sclerosis complex 1 (TSC1 or hamartin) and
TSC2 (or tuberin). TSC1 and TSC2 are products of two dis-
tinct tumor suppressor genes: TSC1 and TSC2, respectively.
These two genes are the genetic loci that are mutated in the
autosomal dominant tumor syndrome tuberous sclerosis
complex (TSC), which is characterized by numerous benign
tumors (13–15). The TSC1–TSC2 complex suppresses the
activation of mTORC1 through a GTPase activating protein
domain located in TSC2. The function of TSC1 is to stabilize
TSC2 and protect it from ubiquitination and degradation (16).
Mouse models with conventional deletion of Tsc1 or Tsc2
exhibit embryonic lethality, making them difﬁcult to use to
study the functional roles of Tsc/mTORC1 signaling in a
speciﬁc organ (14,17). To determine whether the Tsc/
mTORC1 signaling in oocytes takes part in regulation of the
development of primordial follicles, in this study, we deleted
the Tsc1 gene from mouse oocytes in primordial and further
developed follicles. Deletion of Tsc1 led to a global activation
of all primordial follicles around the time of puberty, ending
up with follicular depletion in early adulthood and causing pre-
mature ovarian failure (POF). Thus, the Tsc1–Tsc2 complex in
mouse oocytes is indispensable for sustaining the dormant state
of primordial follicles. Moreover, our results also revealed that
TscandPTENsynergisticallymaintainthedormancyofprimor-
dial follicles: both through suppression of S6K1 activity, but by
downregulation of S6K1 phosphorylation at distinct sites, i.e.
threonine 389 (T389) and T299, respectively. Thus, collabora-
tive functioning of Tsc and PTEN is required to maintain the
quiescence of primordial follicles, which is in turn required to
preserve the length of female reproductive life.
RESULTS
Generation of mutant mice with oocyte-speciﬁc deletion of
Tsc1
To study how the Tsc1–Tsc2 complex in oocytes controls the
development of primordial follicles, we generated mutant
mice in which the Tsc1 gene was deleted in oocytes of primor-
dial and further developed follicles (referred to as OoTsc1
2/2
mice). This was achieved by crossing Tsc1
loxP/loxP mice (14)
with transgenic mice expressing growth differentiation factor
9 (Gdf-9) promoter-mediated Cre recombinase (18)
(Fig. 1A). By western blot, we found that expression of
Tsc1 (hamartin) protein was completely absent in growing
OoTsc1
2/2 oocytes (Fig. 1B), indicating successful deletion
of the Tsc1 gene from oocytes.
We found that the OoTsc1
2/2 females had a normal vaginal
opening at the age of 5–6 weeks (which is the appropriate
age). However, during the period from 6 to 27 weeks of age,
the OoTsc1
2/2 females were found to produce at most
2 litters of normal size, but then became infertile in young
adulthood (i.e. after 12–13 weeks of age) (Fig. 2).
Premature activation of the entire pool of primordial
follicles in OoTsc1
2/2 mice
To determine how the loss of Tsc1 from oocytes impedes
mouse fertility, we compared the ﬁrst wave of postnatal fol-
licular development in OoTsc1
2/2 mice to that in
OoTsc1
þ/þ mice. No apparent morphological difference was
found in post-natal day (PD) 5 ovaries of OoTsc1
2/2 and
OoTsc1
þ/þ mice, where ovaries of both genotypes had
mostly primordial and some primary follicles (Fig. 3A–C).
By PD23, however, the OoTsc1
2/2 ovaries (Fig. 3E) appeared
larger than the OoTsc1
þ/þ ovaries (Fig. 3D). All primordial
follicles were activated in OoTsc1
2/2 ovaries with enlarged
oocytes (Fig. 3F, arrows; Fig. 3H), whereas 74% of the fol-
licles in control ovaries were still at the primordial stage
(Fig. 3D, arrows; Fig. 3H). This leads to higher numbers of
activated follicles in OoTsc1
2/2 ovaries (Fig. 3H, Acti).
There were also more follicles in OoTsc1
2/2 ovaries at
PD23 (Fig. 3H), including transient follicles containing
enlarged oocytes surrounded by ﬂattened pregranulosa cells
(Fig. 3F, arrows), and type 4 and type 5 follicles (Fig. 3H).
Thus, with Tsc1 deleted in oocytes, the entire pool of primor-
dial follicles in OoTsc1
2/2 ovaries had been activated by
Figure 1. Oocyte-speciﬁc deletion of Tsc1 in mice. (A) Schematic represen-
tation of deletion of Tsc1 exons 17 and 18 by Gdf-9-Cre-mediated recombina-
tion in oocytes. (B) Western blots showing the absence of Tsc1 (hamartin)
protein expression in oocytes of OoTsc1
2/2 mice. Oocytes were isolated
from ovaries of 12- to 14-day-old OoTsc1
þ/þ and OoTsc1
2/2 mice as
described in Materials and Methods. For each experiment, material from 3–
5 mice was used per lane. For each lane, 20 mg of protein was loaded.
Levels of b-actin were used as internal controls. The experiments were
repeated three times and representative images are shown.
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before the onset of sexual maturity (19,20) had also been pre-
vented to some extent.
Follicle depletion and POF in early adulthood in
OoTsc1
2/2 mice
By 7 weeks of age, the OoTsc1
2/2 ovaries (Fig. 4B) still
appeared larger than the OoTsc1
þ/þ ovaries (Fig. 4A), due
to higher numbers of activated follicles (Fig. 4J). However,
some of the prematurely activated follicles (especially the
transient follicles with enlarged oocytes) had started to degen-
erate (Fig. 4C, arrows); thus, the total numbers of follicles in
OoTsc1
2/2 ovaries had become less than in OoTsc1
þ/þ
ovaries at this age (Fig. 4J).
By 2 months of age, the OoTsc1
2/2 ovaries (Fig. 4E)
appeared smaller than OoTsc1
þ/þ ovaries (Fig. 4D) because
most of the follicles had been degraded (Fig. 4F, arrows), and
the numbers of healthy follicles were less than those in
OoTsc1
þ/þ ovaries (Fig. 4D). Ovulation had taken place in
OoTsc1
2/2 ovaries, as indicated by the presence of corpora
lutea (CL) (Fig. 4E, arrow). By 3 months of age, OoTsc1
2/2
ovaries were smaller and did not have any healthy follicular
structure (Fig. 4H and I). As a control, the OoTsc1
þ/þ ovaries
were larger, showing healthy follicles and CL (Fig. 4G).
These results indicate that POF had already taken place in
2- to 3-month-old OoTsc1
2/2 mice. In addition, in sera of
3- to 4-month-old OoTsc1
2/2 mice, the levels of follicle-
stimulating hormone (FSH) (Fig. 4K) and luteinizing hormone
(LH) (Fig. 4L) were signiﬁcantly higher when compared with
age-matched OoTsc1
þ/þ mice. Thus, premature activation of
the primordial follicle pool led to follicle depletion and POF
in OoTsc1
2/2 mice in early adulthood.
Enhanced mTORC1 activity in OoTsc1
2/2 oocytes
To elucidate the molecular mechanisms underlying the
accelerated oocyte growth in OoTsc1
2/2 ovaries, we studied
the signaling molecules that are regulated by Tsc in
OoTsc1
2/2 oocytes. First of all, we found that in the
absence of Tsc1, Tsc2 was also absent in OoTsc1
2/2
oocytes (Fig. 5A), conﬁrming that the function of Tsc1 is to
stabilize Tsc2 (16) in oocytes.
mTOR is associated with two distinct complexes, mTORC1
and mTOR complex 2 (mTORC2) (21,22). mTORC1 is
rapamycin-sensitive (23) and promotes cell growth largely
through activation of S6K1 (by phosphorylation of its threo-
nine 389) and through phosphorylation and inactivation of
eukaryotic translation initiation factor 4E (eIF4E)-binding pro-
teins (4E-BPs) (12,24). S6K1 is responsible for phosphoryl-
ation and activation of rpS6, which leads to enhanced
protein translation and ribosome biogenesis (12). 4E-BP1
represses the activity of eIF4E, and phosphorylation of
4E-BP1 by mTORC1 releases its suppression of eIF4E and
promotes protein translation (25). In contrast, mTORC2 is
rapamycin-insensitive and has been shown to phosphorylate
Akt at its serine 473 (S473) (11).
We found that in OoTsc1
2/2 oocytes the activity of
mTORC1 was enhanced, as indicated by the elevated levels
of phosphorylated S6K1 (Fig. 5A, p-S6K1, T389) and phos-
phorylated 4E-BP1 (Fig. 5A, p-4E-BP1, S65) in OoTsc1
2/2
oocytes. The elevated phosphorylation of S6K1 at T389 had
apparently led to an increase in its activity, as phosphorylation
of S6K1 substrate, rpS6, was dramatically elevated in
OoTsc1
2/2 oocytes (Fig. 5A, p-rpS6, S240/4 and S235/6).
In addition, the levels of phosphorylated eIF4B (Fig. 5A,
p-eIF4B, S422) and total eIF4B (Fig. 5A), which is another
S6K1 substrate that takes part in enhancing translation
initiation (26), were higher in OoTsc1
2/2 oocytes than in
OoTsc1
þ/þ oocytes. These data indicate that mTORC1
activity is elevated in OoTsc1
2/2 oocytes.
Enhanced cap-dependent translation initiation in
OoTsc1
2/2 oocytes
rpS6 is a substrate of S6K1 and is one of the 33 40S ribosomal
proteins. 40S ribosomal subunits containing phosphorylated
rpS6 are preferentially used during the formation of translation
initiation complex (27). To determine the functional conse-
quences of enhanced phosphorylation of rpS6 in OoTsc1
2/2
oocytes (Fig. 5A), we performed a cap-binding assay where
the ability of rpS6 to bind the 7-methylguanosine cap structure
(m7GTP) at the 50-end of mRNAs was tested. Such binding
occurs during cap-dependent initiation of translation (28).
WefoundthattheabilityofrpS6tobindtom7GTPcapbeads
was signiﬁcantly elevated in OoTsc1
2/2 oocytes when com-
pared with that in OoTsc1
þ/þ oocytes (Fig. 5B, rpS6 in
m7GTP pull down). As a control, eIF4E, a cap-binding
subunit of the translation initiation complex (28), showed
similar afﬁnity for cap beads in both OoTsc1
2/2 and
OoTsc1
þ/þ oocytes (Fig. 5B, eIF4E). This result suggests that
elevated phosphorylation of rpS6 and eIF4B leads to enhanced
cap-dependent translation initiation in OoTsc1
2/2 oocytes.
Activation of PI3K–Akt signaling is unaltered in
OoTsc1
2/2 oocytes
We found that the level of p-Akt was not elevated in
OoTsc1
2/2 oocytes, either at the basal level or after
Figure 2. Subfertility in mice upon deletion of Tsc1 from oocytes. Comparison
of the cumulative number of pups per OoTsc1
2/2 female (n ¼ 10, red line)
and per OoTsc1
þ/þ female (n ¼ 14, blue line). All OoTsc1
2/2 females
became infertile in young adulthood after week 12–13.
Human Molecular Genetics, 2010, Vol. 19, No. 3 399Figure 3. Activation of the entire pool of primordial follicles upon deletion of Tsc1 from oocytes. (A–F) Morphological analysis of ovaries from OoTsc1
2/2 and
OoTsc1
þ/þ littermates at PD5 and PD23. Ovaries from 5- and 23-day-old OoTsc1
þ/þ and OoTsc1
2/2 mice were embedded in parafﬁn, and serial sections of
8 mm thickness were prepared and stained with hematoxylin. At PD5, similar ovarian morphologies were seen in sections from OoTsc1
þ/þ and OoTsc1
2/2
ovaries (A–C). At PD23, however, OoTsc1
2/2 ovaries were larger (E) than OoTsc1
þ/þ ovaries (D). No primordial follicles could be seen by PD23 in
OoTsc1
2/2 ovaries, and almost all the primordial follicles were activated with apparently enlarged oocytes surrounded by ﬂattened pregranulosa cells (F,
arrows). In OoTsc1
þ/þ ovaries primordial follicles could be readily observed at PD23 (D, arrows). The experiments were repeated at least four times, and
for each time and each age, ovaries from one mouse of each genotype were used. (G and H) Quantiﬁcation of follicle numbers in ovaries of OoTsc1
2/2
and OoTsc1
þ/þ littermates at PD5 and PD23. The numbers of different types of follicles per ovary (mean+SEM) were quantiﬁed as described in Materials
and Methods. Note that although similar numbers of follicles were seen in both genotypes at PD5 (G), no primordial follicles were observed in OoTsc1
2/2
ovaries at PD23, whereas 74% of follicles were still at the primordial follicle stage in OoTsc1
þ/þ ovaries (H). Moreover, the numbers of activated follicles
and of all follicles per OoTsc1
2/2 ovary were signiﬁcantly higher than for OoTsc1
þ/þ ovaries at PD23 (H). The numbers of mice used (n) and results of stat-
istical analyses are given.  P , 0.05,   P , 0.01 and    P , 0.001.
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2/2 mice. (A–I) Morphological analysis of ovaries from OoTsc1
2/2 and OoTsc1
þ/þ lit-
termates at 7 weeks, 2 months and 3 months of age. Ovaries from OoTsc1
2/2 and OoTsc1
þ/þ mice were embedded in parafﬁn and sections of 8 mm thickness
were prepared and stained with hematoxylin. When compared with ovaries of OoTsc1
þ/þ mice (A), OoTsc1
2/2 ovaries still appeared larger at 7 weeks of age
(B). However, many activated follicles in OoTsc1
2/2 ovaries had already degenerated (C, arrows). At 2 months of age, almost all follicles had degenerated in
OoTsc1
2/2 ovaries (F, arrows) and the ovaries were smaller (E) than OoTsc1
þ/þ ovaries (D). By 3 months of age, healthy follicular structures had completely
disappeared in OoTsc1
2/2 ovaries (H and I). Control OoTsc1
þ/þ mice had normal ovarian morphology (G). CL, corpus luteum. (J) Quantiﬁcation of follicle
numbers in ovaries of 7-week-old OoTsc1
2/2 and OoTsc1
þ/þ ovaries. The numbers of different types of follicles per ovary (mean+SEM) were quantiﬁed as
described in Materials and Methods. In 7-week-old OoTsc1
2/2 ovaries, the numbers of healthy follicles were signiﬁcantly reduced compared with OoTsc1
þ/þ
ovaries. The numbers of mice used (n) and results of statistical analyses are given.   P , 0.01,    P , 0.001. (K and L) Levels of FSH and LH in sera of 3- to
4-month-old OoTsc1
þ/þ and OoTsc1
2/2 mice. FSH and LH were measured as described in Materials and Methods. Signiﬁcantly elevated levels of FSH (K) and
LH (L) in adult OoTsc1
2/2 mice were observed. The numbers of mice used (n) and P-values are shown in the ﬁgures.
Human Molecular Genetics, 2010, Vol. 19, No. 3 401stimulation with Kit ligand (KL) (Fig. 5C, p-Akt, S473). Being
a substrate of Akt, the phosphorylation of Foxo3a was not
altered in OoTsc1
2/2 oocytes (data not shown), indicating
that the activation status of Foxo3a was not altered. Moreover,
phosphorylation of S6K1 at T229, which is performed by
PDK1 (29), was unchanged in OoTsc1
2/2 oocytes—either
at basal levels or upon stimulation with KL (Fig. 5C), indicat-
ing that the activation of PDK1 is not affected by loss of Tsc1
in oocytes. These data support the idea that the activation of
PI3K–PDK1–Akt signaling is unaltered in OoTsc1
2/2
oocytes, indicating that mTORC2 activity, which is respon-
sible for phosphorylation of Akt at S473 (11), is not
changed by the loss of Tsc1. As a comparison, the level of
p-S6K1 at T389 (mediated by mTORC1) was constantly elev-
ated in OoTsc1
2/2 oocytes and could not be stimulated further
by treatment with KL (Fig. 5C).
For S6K1 to be active, its T389 and its T229 must both be
phosphorylated (by mTORC1 and PDK1, respectively) (29).
We found that the phosphorylation of S6K1 (T389) and
rpS6 (S235/6) in OoTsc1
2/2 oocytes were dependent on
PI3K/Akt signaling, as pretreatment of OoTsc1
2/2 oocytes
with a PI3K-speciﬁc inhibitor, LY294002, largely suppressed
the phosphorylation of S6K1 (T389) and rpS6 (S235/6)
(Fig. 6A, LY). This indicates that the activity of mTORC1
in oocytes is dependent on PI3K, although PI3K signaling
per se is not changed due to loss of Tsc1 (Fig. 5C).
Rapamycin effectively reverses the overactivation of
primordial follicles in OoTsc1
2/2 ovaries
The phosphorylation of S6K1 (T389) and rpS6 (S235/6) in
OoTsc1
2/2 oocytes was sensitive to the mTORC1-speciﬁc
inhibitor rapamycin (Fig. 6A). To provide in vivo evidence
that it is the elevated mTORC1 activity that drives the overac-
tivation of primordial follicles in OoTsc1
2/2 mice, we
injected rapamycin into OoTsc1
2/2 mice (5 mg/kg body
weight per day), starting from PD4 for 19 days. The mice
were sacriﬁced at PD23 and ovarian morphology was studied.
Figure 5. Studies of mTORC1 and PI3K signaling in OoTsc1
2/2 and OoTsc1
þ/þ oocytes. (A) Comparison of Tsc1/mTORC1 signaling in OoTsc1
2/2 and
OoTsc1
þ/þ oocytes. Oocytes were isolated from ovaries of mice at PD12–14 and western blot was performed as described in Materials and Methods. Loss
of Tsc1 led to complete absence of Tsc2 protein in OoTsc1
2/2 oocytes. mTORC1 signaling in OoTsc1
2/2 oocytes was enhanced, as indicated by elevated
levels of phosphorylated S6K1 (p-S6K1, T389) and phosphorylated rpS6 (p-rpS6, S235/6 and S240/4). Increased phosphorylation of 4E-BP1 (p-4E-BP1,
S65) and eIF4B (p-eIF4B, S422), and elevated total protein levels of eIF4B were seen in OoTsc1
2/2 oocytes. Levels of total S6K1, rpS6, 4E-BP1 and
b-actin were used as internal controls. (B) Enhanced cap-dependent translation initiation in OoTsc1
2/2 oocytes. Oocytes were isolated from ovaries of
OoTsc1
2/2 and OoTsc1
þ/þ mice at PD12–14 and cap-binding assays were performed as described in Materials and Methods. The ability of rpS6 to bind to
m7GTP cap beads was found to be elevated in OoTsc1
2/2 oocytes compared with that in OoTsc1
þ/þ oocytes. Equivalent amounts of protein between precipi-
tates were monitored by the levels of eIF4E, which also binds to the m7GTP beads. Equal amounts of rpS6 in oocyte lysates were also shown. The experiments
were repeated three times. For each experiment, material from 15–20 mice was used per lane. Representative images are shown. (C) Constitutively activated
mTORC1 signaling, but unaltered PI3K–Akt signaling in OoTsc1
2/2 oocytes. Phosphorylation of S6K1 (p-S6K1, T389) was constitutively higher in
OoTsc1
2/2 oocytes, which could not be elevated further by KL treatment. However, phosphorylation of Akt (p-Akt, S473) and S6K1 (p-S6K1, T229),
which are activated by PI3K signaling, was similar in OoTsc1
2/2 and OoTsc1
þ/þ oocytes both at the basal level and upon stimulation by KL (100 ng/ml,
2 min). Levels of total S6K1, Akt, rpS6 and b-actin were used as internal controls.
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2/2 mice that had been
treated with rapamycin, the ovaries were smaller (Fig. 6D)
and typical primordial follicles were found (Fig. 6E,
arrows). On the contrary, in ovaries of PD23 OoTsc1
2/2
mice that were treated with vehicle, the ovaries were larger
(Fig. 6B) and all primordial follicles had been activated,
with enlarged oocytes (Fig. 6C, arrows). Quantiﬁcation of fol-
licle numbers showed that the proportion of primordial fol-
licles in rapamycin-treated OoTsc1
2/2 ovaries was elevated
to 73%, which was similar to the proportion in OoTsc1
þ/þ
ovaries (74%) (Fig. 6F). These results clearly showed that
elevated mTORC1 activity in oocytes is the major driving
force that activates the whole pool of primordial follicles in
OoTsc1
2/2 mice. At the same time, this result also
indicates that suppression of mTORC1 activity in oocytes is
necessary for preservation of primordial follicles in a
dormant state.
Tsc1 and PTEN in oocytes suppress follicular activation
synergistically, but in distinct ways
We have reported earlier that mice lacking Pten in oocytes
(referred to as OoPten
2/2 mice in this study) exhibit accel-
erated activation of primordial follicles (Fig. 7A) (8), which
is most likely achieved through elevated phosphorylation of
S6K1 at T229 (but not at T389), subsequently leading to
Figure 6. Rapamycin effectively reverses the overactivation of primordial follicles in OoTsc1
2/2 ovaries. (A) Activation of S6K1–rpS6 in OoTsc1
2/2 oocytes
is dependent on PI3K and mTORC1 signaling. Oocytes were isolated from ovaries of OoTsc1
2/2 mice at PD12–14 as described in Materials and Methods.
Treatment of oocytes with the PI3K-speciﬁc inhibitor LY294002 (LY, 50 mM) for 1 h was found to largely suppress levels of p-Akt (S473), p-S6K1 (T389)
and p-rpS6 (S235/6), whereas treatment with the mTORC1-speciﬁc inhibitor rapamycin (Rap, 50 nM) for 1 h only suppressed the levels of p-S6K1 (T389)
and p-rpS6 (S235/6), but not the level of p-Akt (S473) in OoTsc1
2/2 oocytes. This suggests that activation of S6K1–rpS6 in OoTsc1
2/2 oocytes is dependent
on both PI3K and mTORC1 signaling. Levels of total Akt, S6K1 and b-actin were used as internal controls. (B–E) The overactivation of primordial follicles in
OoTsc1
2/2 mice can be reversed by treatment with rapamycin. Rapamycin (5 mg/kg body weight) was injected daily into OoTsc1
2/2 mice from PD4 to PD22,
and the ovaries were collected at PD23 for morphological analysis. Ovaries from rapamycin-treated OoTsc1
2/2 mice appeared smaller (D) than the ovaries from
vehicle-treated OoTsc1
2/2 mice (B). Clusters of primordial follicles were seen in rapamycin-treated OoTsc1
2/2 mice at PD23 (E, arrows), whereas all primor-
dial follicles were activated in vehicle-treated OoTsc1
2/2 mice at PD23 (C, arrows). (F) Proportions of primordial follicles (relative to the total number of
follicles) in OoTsc1
þ/þ,O o Tsc1
2/2 (vehicle-treated) and OoTsc1
2/2 (rapamycin-treated) ovaries at PD23. The average percentages of primordial follicles
are shown. The proportion of primordial follicles in rapamycin-treated OoTsc1
2/2 ovaries was found to be elevated to 73%, which was similar to the proportion
in OoTsc1
þ/þ ovaries (74%). The numbers of mice used (n) are shown. Rapa, rapamycin.
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OoPten
2/2 oocytes (9). In the current study, we found
that loss of Tsc1 in oocytes leads to enhanced phosphoryl-
ation of S6K1 at T389 (Fig. 5A), but not at T229
(Fig. 5C). This also leads to elevated activation of rpS6
(Fig. 5A).
Figure 7. Tsc1 and PTEN in oocytes synergistically maintain the quiescence of primordial follicles through distinct ways. (A–C) Morphological analysis of
ovaries from OoPten
2/2,O o Tsc1
2/2 and OoTsc1
2/2;Pten
2/2 mice. At PD23, in OoPten
2/2 (A, arrows) and OoTsc1
2/2 ovaries (B, arrows) all primordial
follicles were activated, with enlarged oocytes. It is noteworthy that in OoTsc1
2/2;Pten
2/2 ovaries, the rate of oocyte growth was further enhanced in a syner-
gistic way (C, arrows) compared with that in singly mutated mice. (D and E) Average oocyte diameters in transient and type 3b follicles of PD23 OoPten
2/2,
OoTsc1
2/2 and OoTsc1
2/2;Pten
2/2 ovaries. One hundred oocytes from randomly selected transient and type 3b follicles were measured as described in
Materials and Methods. Oocytes in OoTsc1
2/2;Pten
2/2 follicles were found to be larger than those in OoPten
2/2 and OoTsc1
2/2 follicles. Results of statistical
analyses are shown.    P , 0.001. (F) Percentages of follicles at different developmental stages in OoPten
2/2,O o Tsc1
2/2 and OoTsc1
2/2;Pten
2/2 ovaries at
PD23. More than 60% of the activated follicles were at the transient follicle stage (Tran) in OoPten
2/2 and OoTsc1
2/2 ovaries, whereas in OoTsc1
2/2;Pten
2/2
ovaries more follicles were at further developed stages (including type 3b, type 4 and type 5 follicles). The numbers of mice used (n) and results of statistical
analyses are given.   P , 0.01,     P , 0.001. (G) Studies of PI3K and mTORC1 signaling in OoPten
þ/þ,O o Pten
2/2,O o Tsc1
þ/þ,O o Tsc1
2/2 and
OoTsc1
2/2;Pten
2/2 oocytes. In OoPten
2/2 oocytes, the levels of p-Akt (T308 and S473) and p-S6K1 (T229), but not of p-S6K1 (T389) were elevated. In
comparison, in OoTsc1
2/2 oocytes, the levels of p-S6K1 (T389) but not of p-Akt (T308 and S473) or p-S6K1 (T229) were elevated. Nevertheless, in
OoTsc1
2/2;Pten
2/2 oocytes, the levels of both p-Akt (T308 and S473) and p-S6K1 (T229 and T389) were elevated, indicating overactivation of both the
PI3K and mTORC1 signaling in doubly mutated oocytes. As a consequence, the phosphorylation (indicating activation) of rpS6 (p-rpS6, S240/4 and S235/
6) in OoTsc1
2/2;Pten
2/2 oocytes was further elevated compared with single-mutant OoTsc1
2/2 or OoPten
2/2 oocytes. Moreover, the protein levels of
rpS6 were also higher in OoTsc1
2/2;Pten
2/2 oocytes. Levels of total Akt, S6K1 and b-actin were used as internal controls. All experiments were repeated
three times. For each experiment, material from 3–5 mice was used per lane. In each lane, 20–30 mg of protein sample was loaded. Representative images
are shown.
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PI3K signaling and the Tsc/mTORC1 signaling within the
oocyte in regulating follicular activation, we crossed
OoTsc1
2/2 mice with OoPten
2/2 mice and studied follicular
development in progeny mice with concurrent loss of Tsc1 and
Pten in oocytes (referred to as OoTsc1
2/2;Pten
2/2 mice). We
found that in OoTsc1
2/2;Pten
2/2 mice, the rate of oocyte
growth was synergistically enhanced further (as shown in
the ovaries of PD23 mice; Fig. 7C, arrows) when compared
with that in single mutant OoPten
2/2 ovaries (Fig. 7A,
arrows) or OoTsc1
2/2ovaries (Fig. 7B, arrows).
To further characterize the rate of oocyte growth in
OoTsc1
2/2;Pten
2/2 mice, we measured the diameters of
oocytes of transient and type 3b follicles in these mice. We
found that the average diameters of oocytes in transient fol-
licles (Fig. 7D) and type 3b follicles (Fig. 7E) in OoTsc1
2/2;
Pten
2/2 ovaries were signiﬁcantly larger than those in
OoPten
2/2 and OoTsc1
2/2 ovaries. In addition, in
OoPten
2/2 and OoTsc1
2/2 ovaries, by PD23 more than
60% of activated follicles were at the transient follicle stage
(Fig.7F, Tran), whereas in OoTsc1
2/2;Pten
2/2 ovaries sig-
niﬁcantly more follicles were found to be type 3b, type 4
and type 5 follicles (Fig. 7F, T3b, T4 and T5). These results
suggest that the concurrent deﬁciencies of Tsc1 and Pten in
oocytes result in synergistically enhanced oocyte growth and
follicular development in OoTsc1
2/2;Pten
2/2 ovaries.
To characterize the underlying signaling events that drive
the enhanced rate of oocyte growth in OoTsc1
2/2;Pten
2/2
mice, we studied the activation status of PI3K signaling and
mTORC1 signaling in doubly mutated oocytes in comparison
to singly mutated OoTsc1
2/2 or OoPten
2/2 oocytes.
As shown in Figure 7G, in OoPten
2/2 oocytes the levels of
p-Akt (T308 and S473) and p-S6K1 (T229), but not p-S6K1
(T389), were elevated. In comparison, in OoTsc1
2/2
oocytes the levels of p-S6K1 (T389) were elevated, whereas
levels of p-Akt (T308 or S473) or p-S6K1 (T229) were not
elevated (Fig. 7G).
In OoTsc1
2/2;Pten
2/2 oocytes, the phosphorylation of Akt
at both T308 and S473 (Fig. 7G, p-Akt, T308 and S473) and
the phosphorylation of S6K1 at T229 and T389 (Fig. 7G,
p-S6K1, T229 and T389) were elevated, indicating a constitu-
tive overactivation of both the pI3K signaling and the
mTORC1 signaling in the doubly mutated oocytes. As a con-
sequence, the phosphorylation (indicating activation) of rpS6
in OoTsc1
2/2;Pten
2/2 oocytes was further elevated com-
pared with single-mutant OoTsc1
2/2 or OoPten
2/2 oocytes
(Fig. 7G, p-rpS6, S235/6, S240/4). Moreover, the expression
of rpS6 was also elevated in OoTsc1
2/2;Pten
2/2 oocytes
(Fig. 7G, rpS6), which is probably a consequence of enhanced
protein translation in the doubly mutated oocytes.
Thus, in combination with our earlier studies on the
OoPten
2/2 mice (8,9), our results show that loss of Tsc1 or
Pten in oocytes both lead to overactivation of rpS6, but
through distinct signaling pathways. PTEN in oocytes sup-
presses follicular activation through negative regulation of
the PI3K signaling, which subsequently inhibits phosphoryl-
ation of S6K1 at its T229 (9) (Fig. 9, T229 of S6K1);
whereas Tsc1 in oocytes suppresses follicular activation by
negative regulation of mTORC1 signaling, which sub-
sequently suppresses the phosphorylation of S6K1 at its
T389 (Fig. 9, T389 of S6K1). Our results thus indicate that
the function of either Tsc1 or PTEN is necessary, but not suf-
ﬁcient, to maintain the quiescence of primordial follicles. In
order to prevent premature follicular activation, a synergisti-
cally combined function of Tsc1 and PTEN is needed to nega-
tively regulate the activation of S6K1–rpS6 signaling in
oocytes.
PDK1 signaling is required for functional S6K1–rpS6 in
OoTsc1
2/2 oocytes
PDK1 is responsible for phosphorylating T229 of S6K1. To
study the functional contribution of PDK1 signaling in the
excessive follicular activation in OoTsc1
2/2 ovaries, we
crossed OoTsc1
2/2 mice with OoPdk1
2/2 mice (9) and
studied follicular development in the progeny (referred to as
OoTsc1
2/2;Pdk1
2/2 mice). In OoTsc1
2/2 ovaries, all pri-
mordial follicles were activated by PD23 (Fig. 8B, arrows),
and the proportion of primordial follicles (compared with
the total number of follicles) was 0% (Fig. 8E). In OoTsc1
2/2;
Pdk1
2/2 ovaries of the same age, however, clusters of primor-
dial follicles were seen (Fig. 8D, arrows), the proportion of
which was elevated to 52% (Fig. 8E). These results show
that the loss of Pdk1 in oocytes partly reversed the overactiva-
tion of primordial follicles in OoTsc1
2/2 ovaries.
In OoTsc1
2/2 oocytes, S6K1 and rpS6 were overactivated
(Fig. 5A). This overactivation of S6K1 signaling was caused
by elevated phosphorylation of its T389 by mTORC1
(Fig. 5A, p-S6K1, T389). On the other hand, activation of
S6K1 also requires phosphorylation of its T229. We found
that the levels of phosphorylated rpS6 and total rpS6 were
largely reduced in OoTsc1
2/2;Pdk1
2/2 oocytes (Fig. 8F,
p-rpS6, S240/4 and rpS6), which was likely caused by less
activity of S6K1 due to downregulation of PDK1-mediated
phosphorylation at its T229 (Fig. 8F, p-S6K1, T229). Thus,
the downregulation of expression and phosphorylation of
rpS6 in OoTsc1
2/2;Pdk1
2/2 oocytes may be the reason for
prevention of the excessive follicular activation seen in
OoTsc1
2/2 ovaries. Thus, it is likely that the activation of pri-
mordial follicles is dependent on both mTOR signaling and
PDK1 function.
DISCUSSION
In this study, by using a mutant mouse model with oocyte-
speciﬁc deletion of Tsc1, we found that the tumor suppressor
Tsc1 functions in oocytes to suppress follicular activation.
Upon deletion of Tsc1 in oocytes, the entire pool of primordial
follicles is prematurely activated. We also found that the
driving force underlying the overactivation of primordial fol-
licles in OoTsc1
2/2 ovaries is elevated mTORC1 activity,
which enhances the activation of S6K1–rpS6 signaling that
promotes protein translation and ribosomal biogenesis in
oocytes. These ﬁndings are corroborated by our parallel
report with mice lacking the Tsc2 gene in oocytes (the
OoTsc2
2/2 mice), in which an almost identical phenotype
was observed (30). Therefore, our studies indicate that the
tumor suppressors Tsc1 and Tsc2 play physiological roles in
oocytes to suppress the activation of primordial follicles. On
Human Molecular Genetics, 2010, Vol. 19, No. 3 405Figure 8. Concurrent loss of Tsc1 and Pdk1 in oocytes largely prevents the overactivation of primordial follicles in OoTsc1
2/2 ovaries. (A–D) Morphological
analysis of ovaries from OoTsc1
2/2 and OoTsc1
2/2;Pdk1
2/2 mice at PD23. In OoTsc1
2/2 ovaries, all primordial follicles were activated (B, arrows).
However, in OoTsc1
2/2;Pdk1
2/2 mice, clusters of primordial follicles were observed (D, arrows). As a result of there being less follicular activation,
OoTsc1
2/2;Pdk1
2/2 ovaries were smaller (C) than OoTsc1
2/2 ovaries (A). (E) Quantiﬁcation of follicle numbers in ovaries of OoTsc1
2/2 and OoTsc1
2/2;
Pdk1
2/2 mice at PD23. The numbers of different types of follicles per ovary (mean+SEM) were quantiﬁed as described in Materials and Methods. No typical
primordial follicles were observed in OoTsc1
2/2 ovaries (0%) at PD23, whereas 52% of follicles in OoTsc1
2/2;Pdk1
2/2 ovaries were at the primordial stage.
The numbers of mice used (n) and results of statistical analyses are given.  P , 0.05,    P , 0.001. (F) Comparison of activation of S6K1–rpS6 signaling in
OoTsc1
2/2 and OoTsc1
2/2;Pdk1
2/2 oocytes. Oocytes were isolated from ovaries of mice at PD12–14 and western blot was performed as described in
Materials and Methods. KL treatment (100 ng/ml, 2 min) was found to lead to a rapid phosphorylation of S6K1 at T229 in OoTsc1
2/2 oocytes, but not in
OoTsc1
2/2;Pdk1
2/2 oocytes, indicating that S6K1 can not be efﬁciently activated in OoTsc1
2/2;Pdk1
2/2 oocytes. The phosphorylation of rpS6 (p-rpS6,
S240/4) and rpS6 expression were downregulated in OoTsc1
2/2;Pdk1
2/2 oocytes. The level of b-actin was used as internal control.
406 Human Molecular Genetics, 2010, Vol. 19, No. 3the basis of our results, we suggest that suppression of
mTORC1 activity by the Tsc1–Tsc2 complex in oocytes is
a prerequisite for maintenance of the quiescent state of primor-
dial follicles in mice, which is required for preservation of the
length of female reproductive life. At the same time, our
results also indicate that elevated mTORC1 activity in the
oocyte is required for follicular activation in mice. We con-
clude that Tsc/mTORC1 signaling in oocytes plays an indis-
pensable role in preserving the primordial follicles in their
dormant state and in triggering the activation of selected pri-
mordial follicles.
Our earlier reports have shown that the PTEN/PI3K–PDK1
signaling is of importance in controlling different develop-
mental courses of primordial follicles (8,9). Deletion of Pten
from mouse oocytes leads to premature activation of the
entire pool of primordial follicles (8), and deletion of Pdk1
in oocytes leads to accelerated depletion of primordial follicles
(9). In the current work, we have shown that the Tsc/mTORC1
signaling in oocytes is equally important for preservation of
the primordial follicles in their dormant state, and it controls
the activation of primordial follicles. Even so, although the
overactivation of primordial follicles observed in OoTsc1
2/2
mice is phenotypically similar to that seen in OoPten
2/2
mice, the Tsc/mTORC1 signaling in oocytes regulates follicu-
lar dormancy and activation in a more distinct way than
PTEN. Although both Tsc and PTEN manipulate follicular
activation through negative regulation of the activation of
S6K1–rpS6 in oocytes, Tsc suppresses the phosphorylation
of S6K1 at its T389, as shown in the current study, whereas
PTEN suppresses the phosphorylation of S6K1 at its T229,
as shown earlier (9). Suppression of phosphorylation of both
threonine sites results in inhibition of S6K1–rpS6 activation
in oocytes, which helps to preserve the quiescence of primor-
dial follicles. Thus, our results from the OoTsc1
2/2 and
OoPten
2/2 mice show that elevated phosphorylation of
either T389 or T229 of S6K1, due to deletion of Tsc1 or
Pten, leads to enhanced activation of S6K1–rpS6 signaling,
which subsequently causes accelerated protein translation in
oocytes. This appears to be the reason for the rapid oocyte
enlargement and accelerated follicular activation seen in
OoTsc1
2/2 and OoPten
2/2 mice.
Interestingly, although Tsc/mTORC1 signaling has been
proposed to be downstream of PTEN/PI3K signaling in
some cell types (15), the functions of both PTEN and Tsc1
in maintaining the quiescence of primordial follicles do not
seem to be in a upstream and downstream arrangement in
mouse oocytes. Instead, PTEN and Tsc1 appear to suppress
follicular activation in parallel, in a synergistic and collabora-
tive way. This notion is supported by our results that double
deletion of Tsc1 and Pten leads to further synergistically
enhanced oocyte growth when compared with singly
mutated mice. These results indicate that in order to maintain
the quiescence of primordial follicles, phosphorylation of both
T389 and T229 of S6K1 in oocytes must be suppressed by Tsc
and PTEN, respectively (Fig. 9), through which the activation
of S6K1–rpS6 signaling is suppressed. As a result, primordial
follicles are prevented from being activated. At the same time,
activation of primordial follicles seems to depend on the func-
tioning of both intra-oocyte mTOR and PDK1 signaling, a
notion that is supported by our ﬁnding that overactivation of
primordial follicles in OoTsc1
2/2 ovaries was largely
reversed by concurrent loss of Pdk1.
The regulation of Tsc/mTORC1–S6K1–rpS6 signaling in
oocytes is likely to play a role in determining the course of
development of primordial follicles. It is possible that Tsc
adjusts mTORC1 activity in oocytes to an optimal level, so
that the pool of primordial follicles is maintained in a
dormant but surviving condition. On the other hand, demise
of primordial follicles could be caused by suppression of
mTORC1 signaling in oocytes, and activation of primordial
follicles appears to be the result of elevated mTORC1 activity
in oocytes. On the basis of the several lines of evidence accu-
mulated, we believe that the Tsc/mTORC1–S6K1–rpS6 sig-
naling and the PTEN/PI3K–PDK1–S6K1–rpS6 signaling in
oocytes regulate the development of primordial follicles in a
coordinated way, which ensures the proper length of female
reproductive life.
More than a decade ago, it was hypothesized that
resting primordial follicles may be under constant inhibitory
Figure 9. Tsc/mTORC1 and PTEN/PI3K signaling in oocytes controls the
quiescence and activation of primordial follicles in a synergistic and collabora-
tive way. On the basis of the evidence accumulated, we propose that PTEN in
oocytes suppresses follicular activation through negative regulation of the
PI3K signaling and of the function of PDK1, which leads to subsequent inhi-
bition of phosphorylation of S6K1 at T229 by PDK1 (9). On the other hand,
Tsc1 in oocytes suppresses follicular activation by negative regulation of
mTORC1 signaling, leading to suppressed phosphorylation of S6K1 at
T389. Thus, in this scheme both PTEN and Tsc suppress the phosphoryl-
ation/activation of rpS6, but by regulating the phosphorylation of distinct
threonine residues in S6K1. We propose that collaborative, synergistic func-
tions of Tsc1–Tsc2 and PTEN are required to negatively regulate the acti-
vation of S6K1–rpS6 signaling, which in turn facilitate maintenance of the
quiescence of primordial follicles. A reduction in the activities of Tsc1–
Tsc2 or PTEN, or both, would lead to premature follicular activation. Also
shown in the illustration is rapamycin, which is an mTORC1 speciﬁc inhibitor.
P, phosphorylation; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phos-
phatidylinositol 3,4,5-trisphosphate.
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years, this hypothesis has been shown to be true with several
lines of evidence from genetically modiﬁed mouse models
(reviewed in 3,32). It is apparent now that Tsc1, Tsc2 and
PTEN in oocytes are part of the inhibitory mechanisms that
maintain the quiescence of primordial follicles. Other similar
inhibitory molecules include the cyclin-dependent kinase
(Cdk) inhibitor p27
kip1 (p27 or Cdkn1b) (33), which functions
in both oocytes and pregranulosa cells to suppress follicular
activation, and Foxo3a, a transcription factor that functions
downstream of PTEN/PI3K signaling (8) in oocytes and sup-
presses follicular activation (34,35).
It is noteworthy that mice lacking Tsc1, Tsc2 and Pten in
oocytes, or mice lacking p27, all suffer from POF (8,30,33).
The POF in these mutant mice is caused by a similar overac-
tivation of the follicular pool, which is followed by follicular
depletion. On the contrary, deletion of Pdk1 or Rps6 in oocytes
also causes POF, but as a result of accelerated depletion of pri-
mordial follicles directly from their dormant state (9).
Thus, the two types of POF, as observed in different mutant
mouse models, may represent distinct etiologies of POF in
humans.
In women, reproductive lifespan and menopausal age are
determined by the ovarian reserve, i.e. by the size and persist-
ence of the primordial follicle pool. The results of the current
study and recent reports suggest that the deregulation of sig-
naling events in oocytes such as Tsc/mTORC1 signaling,
PTEN/PI3K signaling (8,9) and the p27-Cdk system (33),
may also be the reasons for the defects in primordial follicle
development in humans, which can result in pathological con-
ditions of the ovary, including POF and infertility. In this
sense, our work may have broad physiological and clinical
implications. We believe that comprehension of signaling net-
works in oocytes will open up new avenues for a better under-
standing of ovarian physiology and pathology.
MATERIALS AND METHODS
Mice
Tsc1
loxP/loxP mice with a mixed genomic background of
129S4/SvJae and C57BL/6J (14), Pten
loxP/loxP mice (8) and
Pdk1
loxP/loxP mice (36,37) with a C57BL/6J genomic back-
ground were crossed with transgenic mice that carried Gdf-9
promoter-mediated Cre recombinase which had a C57BL/6J
background (8,18). After multiple rounds of crossing, we
obtained homozygous mutant female mice lacking Tsc1 in
oocytes (OoTsc1
2/2 mice), mice lacking Pten in oocytes
(OoPten
2/2 mice), mice lacking both Tsc1 and Pten in
oocytes (OoTsc1
2/2;Pten
2/2 mice) and mice lacking both
Tsc1 and Pdk1 in oocytes (OoTsc1
2/2;Pdk1
2/2 mice).
Control mice that do not carry the Cre transgene are referred
to as OoTsc1
þ/þ,O o Pten
þ/þ or OoPdk1
þ/þ mice. The mice
were housed under controlled environmental conditions
with free access to water and food. Illumination was on
between 06.00 and 18.00 h. Experimental protocols were
approved by the regional Ethics Committee of Umea ˚ Univer-
sity, Sweden.
Reagents, antibodies and immunological detection methods
The rabbit polyclonal antibodies to Akt, phospho-Akt (S473),
phospho-rpS6 (S235/236 and S240/244), tuberin/Tsc2, hamar-
tin/Tsc1, phospho-eIF4B (S422), eIF4B, phospho-4E-BP1
(S65) and phospho-S6K1 (T389) and also rabbit monoclonal
antibodies to eIF4E, 4E-BP1 and S6K1 were obtained from
Cell Signaling Technologies (Beverly, MA, USA). Mouse
monoclonal antibody to rpS6 was purchased from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The polyclo-
nal antibody to phospho-S6K1 (T229) was purchased from
R&D Systems (Minneapolis, MN, USA). Mouse monoclonal
antibody to b-actin, polyethylene glycol 400 and Tween-80
were purchased from Sigma-Aldrich Sweden AB (Stockholm,
Sweden). 7-Methyl GTP-sepharose was purchased from GE
Healthcare (Buckinghamshire, UK). The PI3K-speciﬁc inhibi-
tor LY 294002, the mTORC1-speciﬁc inhibitor rapamycin and
recombinant mouse KL were obtained from EMD Biosciences
(San Diego, CA, USA). Western blots were carried out accord-
ing to the instructions of the suppliers of the different anti-
bodies and visualized using the ECL Plus Western Blotting
Detection System (Amersham Biosciences, Uppsala, Sweden).
Quantiﬁcation of ovarian follicles and histological analysis
Quantiﬁcation of ovarian follicles was performed as pre-
viously described (8). Brieﬂy, ovaries were ﬁxed in 4% paraf-
ormaldehyde, dehydrated and embedded in parafﬁn. To count
the numbers of follicles, parafﬁn-embedded ovaries were seri-
ally sectioned at 8 mm thickness and stained with hematoxylin
for morphological observation. Ovarian follicles at different
stages of development, including primordial follicles and acti-
vated follicles (including transient follicles containing
enlarged oocytes surrounded by ﬂattened pregranulosa cells,
type 3b, type 4, type 5 and type 6 follicles) were counted in
all sections of an ovary, based on the well-accepted standards
established by Pedersen and Peters (38). Follicles that con-
tained oocytes with clearly visible nuclei were scored in
each section, as previously reported (39). Judged from
careful morphological analysis, the incidence of counting the
same follicle twice or of missing a follicle was low.
Measurement of oocyte diameters in transient and primary
follicles
One hundred transient follicles and 100 primary (type 3b) fol-
licles were randomly selected from parafﬁn sections of ovaries
from at least three mice of each genotypes. The diameters of
oocytes were measured using AxioVision software release
4.2 (Carl Zeiss MicroImaging GmbH, Go ¨ttingen, Germany)
and a Leica DMLB microscope.
Isolation of oocytes from post-natal mouse ovaries and
stimulation of starved oocytes with KL
Isolation and lysis of oocytes were performed as previously
described (8). For stimulation with KL, equal amounts of
oocytes were aliquoted into wells of a 24-well plate. Typi-
cally, each well contained oocytes obtained from 3–5
OoTsc1
2/2 and OoTsc1
þ/þ mice that were 12–14 days old.
408 Human Molecular Genetics, 2010, Vol. 19, No. 3The oocytes were ﬁrst starved by culturing them in serum-free
DMEM/F12 medium for 4 h, followed by treatment with
100 ng/ml KL for 2 min. After stimulation with KL, the
24-well plate was chilled on ice and oocytes were lysed for
western blot analysis.
Cap-binding assay
The 50-end of all nuclear-transcribed mRNAs carries a
7-methylguanosine cap structure (m
7GpppN, where N rep-
resents any nucleotide) (40). Phosphorylation of rpS6 facili-
tates its recruitment to the cap complex and stimulates
assembly of the translation initiation complex (41). To
measure the ability of rpS6 in oocytes to bind to the
7-methylguanosine cap complex, 50–100 mg of oocyte
lysate was incubated with 7-methyl-GTP Sepharose beads
for 2 h. Immunoprecipitates were washed three times in lysis
buffer and were subjected to western blot for detection of
rpS6. Equivalent levels of protein between precipitates were
monitored through analysis of eIF4E, a cap-binding subunit
of the translation initiation complex (40).
Measurement of serum hormone levels
Adult female OoTsc1
2/2 mice of 3- to 4-month-old were
killed randomly due to lack of regular estrus cycles; control
OoTsc1
þ/þ female mice of similar age were killed at the
estrus stage based on vaginal smears, in order to measure gon-
adotropin levels during the follicular growth phase but not the
ovulation phase. Serum hormone levels were determined by
immunoassay as described previously for FSH (42) and LH
(43).
In vivo treatment of OoTsc1
2/2 mice with rapamycin
Rapamycin was dissolved in a vehicle containing 5.2%
Tween-80 and 5.2% polyethylene glycol 400. For daily intra-
peritoneal injection of the mice, a dosage of 5 mg/kg body
weight was used. The OoTsc1
2/2 and OoTsc1
þ/þ mice
were injected daily from PD4 to PD22 and were killed at
PD23. The ovaries were then ﬁxed in 4% paraformaldehyde,
dehydrated and embedded in parafﬁn. For morphological
observation, parafﬁn-embedded ovaries were sectioned at
8 mm thickness and stained with hematoxylin. As controls,
mice injected with vehicle were used.
Statistical analysis
All experiments were repeated at least three times. For com-
parisons of follicle numbers and hormone levels, differences
between the two groups were calculated with Student’s
t-test, and a difference was considered to be signiﬁcant if
P , 0.05.
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